Centocor, Inc. announced that a Biologics License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of golimumab (CNTO 148) as a monthly subcutaneous treatment for adults with active forms of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Read full story
Title: Rheumatoid Arthritis Treatment Guidelines Updated Category: Health News Created: 6/27/2008 2:00:00 AM Last Editorial Review: 6/27/2008
Read full story
Copyright © 2008 ScoutNews LLC. All rights reserved. THURSDAY, June 26 (HealthDay News) — New recommendations for the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) have been developed by the American College of Rheumatology.
Read full story
THURSDAY, June 26 (HealthDay News) — New recommendations for the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) have been developed by the American College of Rheumatology.
Read full story
